[artículo] 
inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 2 (Abril) . - pp. 151-158

Título :	Efficacy of pregabalin in the treatment of generalized anxiety disorder : Double-blind, placebo-controlled comparison of bid versus tid dosing
Tipo de documento:	texto impreso
Autores:	Robert B. Pohl, Autor ; Douglas E. Feltner, Autor ; Ronald R. Fieve, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 151-158
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastornos de ansiedad, Pregabalina, Ácido gamma-aminobutírico.
Resumen:	Pregabalin is a new anxiolytic that acts as a presynaptic inhibitor of the release of excessive levels of excitatory neurotransmitters by selectively binding to the α2-δ subunit of voltage-gated calcium channels. The current study evaluated the anxiolytic efficacy of BID versus TID dosing of pregabalin in patients with generalized anxiety disorder.
Link:	./index.php?lvl=notice_display&id=30915

[artículo] Efficacy of pregabalin in the treatment of generalized anxiety disorder : Double-blind, placebo-controlled comparison of bid versus tid dosing [texto impreso] / Robert B. Pohl, Autor ; Douglas E. Feltner, Autor ; Ronald R. Fieve, Autor . - 2023 . - pp. 151-158.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 2 (Abril) . - pp. 151-158

Palabras clave:	Trastornos de ansiedad, Pregabalina, Ácido gamma-aminobutírico.
Resumen:	Pregabalin is a new anxiolytic that acts as a presynaptic inhibitor of the release of excessive levels of excitatory neurotransmitters by selectively binding to the α2-δ subunit of voltage-gated calcium channels. The current study evaluated the anxiolytic efficacy of BID versus TID dosing of pregabalin in patients with generalized anxiety disorder.
Link:	./index.php?lvl=notice_display&id=30915